WhaleWatch logoWhaleWatch
Sign inStart for ₹1
Smart Money Alert
Emcure Pharmaceuticals Limited logo

Emcure Pharmaceuticals Limited

New PositionBlock Deal
EMCUREPharmaceuticalsMarket Cap₹44K Cr
Deal value
₹25.00 Cr
Deal price
₹1,817.00
Shares
1.38 L
Trade date
25 Jun 2026
Since alert+26.4%₹1,849.50 → ₹2,337.80
Nifty 50+7.7%
Morgan Stanley
Morgan Stanley
Foreign Investor
The move

Morgan Stanley bought 1,37,590 shares of Emcure Pharmaceuticals for ₹25.00 Cr at ₹1817.00 apiece in a block deal. This transaction occurred on June 25, 2026.

About Emcure Pharmaceuticals Limited
+ FollowVisit stock

A global pharmaceutical manufacturer established in 1981, Emcure Pharmaceuticals produces and markets a comprehensive range of drug formulations across multiple therapeutic areas for domestic and international markets. The company operates manufacturing facilities that serve patients globally, focusing on both generic and specialty pharmaceutical products. Emcure's diversified operations and geographic presence establish it as a significant player in the pharmaceutical industry.

About Morgan Stanley
+ FollowVisit investor

US-based global investment bank. India FPI activity covers proprietary, market-making and client flows in listed Indian equities.

Get the next move the moment it happens.
Follow Morgan Stanley and Emcure Pharmaceuticals Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
Explore
Emcure Pharmaceuticals Limited shareholdersMorgan Stanley's portfolioAll investorsAll stocks
🤖 We track their every move, post, interview and article. Obsessively.
⚡ Every move reaches your feed in minutes, while it still carries an edge
📊 Stake changes, bulk deals and insider trades, all tracked in one place
📰 A two-minute morning brief, so you start the day already ahead
Emcure Pharmaceuticals Limited
More moves in Emcure Pharmaceuticals Limited
Government Pension Fund Global (Norway)New position
Government Pension Fund Global (Norway) now holds 20,00,000 shares of Emcure Pharmaceuticals, representing a 1.05% stake, up from under 1% in the prior update.
19 Oct 2026
Read more
Kotak Mutual FundNew position
Kotak Mutual Fund added over 1.31% of the company in the quarter and now holds 2.31%, or 43,81,625 shares.
19 Oct 2026
Read more
Nippon India Mutual FundDecreased
Nippon India Mutual Fund trimmed its stake in Emcure Pharmaceuticals from 1.95% to 1.19%, selling 14,36,943 shares.
19 Oct 2026
Read more
Aditya Birla Sun Life Mutual FundIncreased
Aditya Birla Sun Life Mutual Fund raised its stake in Emcure Pharmaceuticals from 1.31% to 1.45% by acquiring 2,56,640 shares.
19 Oct 2026
Read more
HSBC Mutual FundNew position
HSBC Mutual Fund bought 1,37,590 shares of Emcure Pharmaceuticals for ₹25.00 Cr at ₹1,817.00 apiece in a block deal.
25 Jun 2026
Read more
See all moves
Morgan Stanley
More moves by Morgan Stanley
5newest moves
Members only
Xxxxxx Xxxxxxxxxxxx xxxxxxx xxx xxxxx
Xxxxxxxx Xxxxxxxxxxxx xxxxx xx xxxxxxx
Xxxxx Xxxxxxxxxxxxxx xxxxxx xxx xxxx
Unlock all 5 moves
See all moves